Stimcell Energetics (STME) Liabilities and Shareholders Equity (2011 - 2026)
Stimcell Energetics' quarterly Liabilities and Shareholders Equity came in at $34521.0 in Q1 2026, up 101.76% year-on-year from $17110.0 in Q1 2025, and down 34.05% quarter-over-quarter from $52345.0 in Q4 2025.
Stimcell Energetics has reported Liabilities and Shareholders Equity for 15 years, with the latest figure at $34521.0 in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 101.76% year-over-year to $34521.0; the trailing twelve-month figure through Feb 2026 stood at $124475.0 (changed 0.4% YoY), and the FY2025 full-year result was $21222.0, down 53.99% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $34521.0, down from $52345.0 in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $103270.0 in Q2 2023, with the low at $13896.0 in Q1 2023.
- Average Liabilities and Shareholders Equity over 5 years is $40093.2, with a median of $34521.0 recorded in 2026.
- Year-over-year, Liabilities and Shareholders Equity surged 489.51% in 2024 and tumbled 79.11% in 2025.
- Tracing STME's Liabilities and Shareholders Equity over 5 years: stood at $24022.0 in 2022, then decreased by 4.74% to $22883.0 in 2023, then surged by 67.57% to $38346.0 in 2024, then jumped by 36.51% to $52345.0 in 2025, then plunged by 34.05% to $34521.0 in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $34521.0 (Q1 2026), $52345.0 (Q4 2025), and $16387.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Stimcell Energetics | - | - | - | 34,521.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 34,521.00 |
| Nov 30, 2025 | 52,345.00 |
| Aug 31, 2025 | 16,387.00 |
| May 31, 2025 | 21,222.00 |
| Feb 28, 2025 | 17,110.00 |
| Nov 30, 2024 | 38,346.00 |
| Aug 31, 2024 | 22,397.00 |
| May 31, 2024 | 46,122.00 |
| Feb 29, 2024 | 81,918.00 |
| Nov 30, 2023 | 22,883.00 |
| Aug 31, 2023 | 62,326.00 |
| May 31, 2023 | 103,270.00 |
| Feb 28, 2023 | 13,896.00 |
| Nov 30, 2022 | 24,022.00 |
| Aug 31, 2022 | 28,576.00 |
| May 31, 2022 | 41,344.00 |
| Feb 28, 2022 | 54,900.00 |
| Nov 30, 2021 | 72,574.00 |
| Aug 31, 2021 | 101,896.00 |
| May 31, 2021 | 52,242.00 |
| Feb 28, 2021 | 100,043.00 |
| Nov 30, 2020 | 97,721.00 |
| Aug 31, 2020 | 238,588.00 |
| May 31, 2020 | 159,179.00 |
| Feb 29, 2020 | 224,562.00 |
| Nov 30, 2019 | 402,994.00 |
| Aug 31, 2019 | 450,312.00 |
| May 31, 2019 | 190,541.00 |
| Feb 28, 2019 | 221,948.00 |
| Nov 30, 2018 | 95,152.00 |
| Aug 31, 2018 | 51,968.00 |
| May 31, 2018 | 45,259.00 |
| Feb 28, 2018 | 162,680.00 |
| Nov 30, 2017 | 376,337.00 |
| Aug 31, 2017 | 532,302.00 |
| May 31, 2017 | 293,728.00 |
| Feb 28, 2017 | 334,990.00 |
| May 31, 2016 | 268,927.00 |
| May 31, 2014 | 1,201.00 |
| May 31, 2013 | 10,979.00 |
| Feb 28, 2013 | 12,579.00 |
| Nov 30, 2012 | 18,910.00 |
| May 31, 2012 | 23,615.00 |
| Feb 29, 2012 | 30,017.00 |
| Nov 30, 2011 | 17.00 |
| Aug 31, 2011 | 17.00 |
| May 31, 2011 | 17.00 |